Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immunoglobulin

Overview

Journal Clin Exp Med

Specialty General Medicine

Date 2005 Dec 20

PMID 16362793

Citations 26

Authors

A Ephrem

N Misra

G Hassan

S Dasgupta

S Delignat

J-P Duong Van Huyen

S Chamat

F Prost

S Lacroix-Desmazes

S V Kavery

M D Kazatchkine

Affiliations

Soon will be listed here.

Abstract

Intravenous immunoglobulin (IVIg) has been used in the treatment of primary and secondary antibody deficiencies for over two decades. Since the early 1980s, the therapeutic efficacy of IVIg has been established in idiopathic thrombocytopenic purpura, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, dermatomyositis and Kawasaki syndrome, and the prevention of graft versus host disease in recipients of allogeneic bone marrow transplants. Its use has also been reported in a large number of other autoimmune and systemic inflammatory conditions. In this review, we discuss the mechanisms by which IVIg exerts immunomodulatory effects in immune pathologies.

Citing Articles

Protecting children and adults with primary antibody deficiencies against common and emergent pathogens and non-infectious complications.

Neth O, Mahlaoui N, Cunningham-Rundles C Clin Exp Immunol. 2024; 218(2):136-150.

PMID: 39011978 PMC: 11482499. DOI: 10.1093/cei/uxae059.

Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosis.

Speca S, Farhat M, Jendoubi M, Guerrier T, Sanges S, Staumont-Salle D Sci Rep. 2023; 13(1):15102.

PMID: 37700078 PMC: 10497569. DOI: 10.1038/s41598-023-42464-9.

The Effect of a Combined Ganciclovir, Methylprednisolone, and Immunoglobulin Regimen on Survival and Functional Outcomes in Patients With Japanese Encephalitis.

Miao W, Guo J, Zhang S, Shen N, Shang X, Liu F Front Neurol. 2021; 12:711674.

PMID: 34803868 PMC: 8600080. DOI: 10.3389/fneur.2021.711674.

ABO incompatibility in renal transplantation.

Mohamed M, Sweeney T, Alkhader D, Nassar M, Alqassieh A, Lakhdar S World J Transplant. 2021; 11(9):388-399.

PMID: 34631470 PMC: 8465511. DOI: 10.5500/wjt.v11.i9.388.

Open MHC Class I Conformers: A Look through the Looking Glass.

Arosa F, Esgalhado A, Reste-Ferreira D, Cardoso E Int J Mol Sci. 2021; 22(18).

PMID: 34575902 PMC: 8470049. DOI: 10.3390/ijms22189738.